201 related articles for article (PubMed ID: 30918199)
61. Altered pathways and targeted therapy in double hit lymphoma.
Zhuang Y; Che J; Wu M; Guo Y; Xu Y; Dong X; Yang H
J Hematol Oncol; 2022 Mar; 15(1):26. PubMed ID: 35303910
[TBL] [Abstract][Full Text] [Related]
62. Double hit lymphoma: from biology to therapeutic implications.
Burotto M; Berkovits A; Dunleavy K
Expert Rev Hematol; 2016 Jul; 9(7):669-78. PubMed ID: 27166590
[TBL] [Abstract][Full Text] [Related]
63. Management of Patients with MYC-Altered Lymphomas.
Landsburg DJ
Curr Hematol Malig Rep; 2016 Jun; 11(3):208-17. PubMed ID: 26983958
[TBL] [Abstract][Full Text] [Related]
64. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
65. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).
Zeng D; Desai A; Yan F; Gong T; Ye H; Ahmed M; Nomie K; Romaguera J; Champlin R; Li S; Wang M
Am J Clin Oncol; 2019 Mar; 42(3):304-316. PubMed ID: 29419530
[TBL] [Abstract][Full Text] [Related]
66. Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma.
Takeoka K; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Hayashida M; Ohno H
Ann Hematol; 2021 Dec; 100(12):3043-3045. PubMed ID: 32895753
[No Abstract] [Full Text] [Related]
67. A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma.
Ichinohasama R; Miura I; Funato T; Sato I; Suzuki C; Saito Y; Decoteau JF; Myers JB; Kadin ME; Sawai T; Ooya K
Cancer Genet Cytogenet; 1998 Jul; 104(1):19-27. PubMed ID: 9648553
[TBL] [Abstract][Full Text] [Related]
68. Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.
Herrera AF; Mei M; Low L; Kim HT; Griffin GK; Song JY; Merryman RW; Bedell V; Pak C; Sun H; Paris T; Stiller T; Brown JR; Budde LE; Chan WC; Chen R; Davids MS; Freedman AS; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; Murata-Collins J; Nademanee AP; Palmer JM; Pihan GA; Pillai R; Popplewell L; Siddiqi T; Sohani AR; Zain J; Rosen ST; Kwak LW; Weinstock DM; Forman SJ; Weisenburger DD; Kim Y; Rodig SJ; Krishnan A; Armand P
J Clin Oncol; 2017 Jan; 35(1):24-31. PubMed ID: 28034071
[TBL] [Abstract][Full Text] [Related]
69. [MYC-associated B-cell lymphomas: pathophysiology and treatment].
Nitta H
Rinsho Ketsueki; 2019; 60(3):155-164. PubMed ID: 31068510
[TBL] [Abstract][Full Text] [Related]
70. A double-hit High-grade B-cell lymphoma with three-way translocation t(3;8;14)(q27;q24;q32) involving BCL6, MYC, and IGH.
De Paoli E; Bandiera L; Ravano E; Cesana C; Grillo G; Mancini V; De Canal G; Bonoldi E; Soriani S
Clin Case Rep; 2018 Dec; 6(12):2411-2415. PubMed ID: 30564339
[TBL] [Abstract][Full Text] [Related]
71. Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization.
Ueda Y; Nishida K; Miki T; Horiike S; Kaneko H; Yokota S; Misawa S; Abe T; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 1997 Dec; 99(2):102-7. PubMed ID: 9398863
[TBL] [Abstract][Full Text] [Related]
72. An intravascular large B-cell lymphoma with a t(3;14)(q27;q32) translocation.
Cui J; Liu Q; Cheng Y; Chen S; Sun Q
J Clin Pathol; 2014 Mar; 67(3):279-81. PubMed ID: 24357441
[TBL] [Abstract][Full Text] [Related]
73. [Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Sakai R; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1105-8. PubMed ID: 16440771
[TBL] [Abstract][Full Text] [Related]
74. Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.
Tumati V; Trivedi L; Li HC; Patel P; Scaglioni PP; Vusirikala M; Sadeghi N; Rizvi S; Chen W; Wachsmann J; Collins R; Desai NB
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1126-1132. PubMed ID: 29722657
[TBL] [Abstract][Full Text] [Related]
75. Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
Liu Y; Azizian NG; Dou Y; Pham LV; Li Y
J Hematol Oncol; 2019 Nov; 12(1):119. PubMed ID: 31752970
[TBL] [Abstract][Full Text] [Related]
76. [Doublehit lymphomas - review of the literature and case report].
Smardová J; Moulis M; Lišková K; Koptíková J; Hrabálková R; Klusáková J
Klin Onkol; 2014; 27(1):24-32. PubMed ID: 24635434
[TBL] [Abstract][Full Text] [Related]
77. "Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.
Wu D; Wood BL; Dorer R; Fromm JR
Am J Clin Pathol; 2010 Aug; 134(2):258-65. PubMed ID: 20660329
[TBL] [Abstract][Full Text] [Related]
78. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.
Caponetti GC; Dave BJ; Perry AM; Smith LM; Jain S; Meyer PN; Bast M; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Aoun P; Fu K; Greiner TC; Chan WC; Sanger WG; Weisenburger DD
Leuk Lymphoma; 2015; 56(11):3082-9. PubMed ID: 25827211
[TBL] [Abstract][Full Text] [Related]
79. De novo acute B cell leukemia/lymphoma with t(14;18).
Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
[TBL] [Abstract][Full Text] [Related]
80. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
